{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:07:56Z","timestamp":1744650476592},"reference-count":55,"publisher":"Termedia Sp. z.o.o.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatologia"],"published-print":{"date-parts":[[2022,4,30]]},"abstract":"<jats:p>Since the 1990s, polymyalgia rheumatica (PMR) has been reported as a possible adverse event following immunization (AEFI). The aim of this narrative review is to provide an overview of PMR (and PMR-like syndromes) following the most common types of COVID-19 vaccines, namely mRNA (tozinameran and mRNA-1273) and adenovirus-vectored (ChAdOx1-S) vaccines. To date, published literature reports few cases of PMR as vaccine-linked AEFI. Yet Vigibase, the WHO pharmacovigilance database, reports a few hundred cases. &lt;br \/&gt;\nBased on these data, we address the question whether PMR\/PMR-like syndromes following COVID-19 vaccines can be a true adverse or a coincidental event, and discuss its possible pathogenetic mechanisms.<\/jats:p>","DOI":"10.5114\/reum.2022.115665","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T06:30:26Z","timestamp":1652855426000},"page":"142-147","source":"Crossref","is-referenced-by-count":8,"title":["Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature"],"prefix":"10.5114","volume":"60","author":[{"given":"Ciro","family":"Manzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Isetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"ref-785981","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31825-1"},{"key":"ref-785982","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00919-2"},{"key":"ref-785983","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23132"},{"key":"ref-785984","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213883"},{"key":"ref-785985","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7090092"},{"key":"ref-785986","doi-asserted-by":"publisher","DOI":"10.1002\/art.24459"},{"key":"ref-785987","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.005"},{"key":"ref-785988","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.025296"},{"key":"ref-785989","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2018.1107"},{"key":"ref-785990","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00705-5"},{"key":"ref-785991","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_298_17"},{"key":"ref-785992","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.20008"},{"key":"ref-785993","doi-asserted-by":"publisher","DOI":"10.1002\/art.34356"},{"key":"ref-785994","first-page":"9","article-title":"[La polimialgia reumatica: cosa \u00e8 utile sapere per il geriatra territoriale]","volume":"7","author":"Manzo C","year":"2009","unstructured":"Manzo C. [La polimialgia reumatica: cosa \u00e8 utile sapere per il geriatra territoriale].  Geriatria Extraospedaliera 2009;  7:  9\u2013 11 [Article in Italian].","journal-title":"Geriatria Extraospedaliera"},{"key":"ref-785995","doi-asserted-by":"publisher","DOI":"10.1701\/2695.27559"},{"key":"ref-785996","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2010.09.001"},{"key":"ref-785997","doi-asserted-by":"publisher","DOI":"10.35841\/medical-oncology.3.2.21-22"},{"key":"ref-785998","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328359e780"},{"key":"ref-785999","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2018.76900"},{"key":"ref-786000","first-page":"755","article-title":"Polymyalgic manifestations in different conditions mimicking polymyalgia rheumatica","volume":"18","author":"Gonzalez-Gay MA","year":"2000","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, . Polymyalgic manifestations in different conditions mimicking polymyalgia rheumatica. Clin Exp Rheumatol 2000; 18: 755\u2013 759.","journal-title":"Clin Exp Rheumatol"},{"key":"ref-786001","first-page":"627","article-title":"Polymyalgia rheumatica: the great imitator","volume":"21","author":"Gazit T","year":"2019","unstructured":"Gazit T, Kibari A, Nasrallah N, . Polymyalgia rheumatica: the great imitator. Isr Med Assoc J 2019; 21: 627\u2013 628.","journal-title":"Isr Med Assoc J"},{"key":"ref-786002","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2018.74740"},{"key":"ref-786003","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key431"},{"key":"ref-786004","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key431"},{"key":"ref-786005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.55563\/clinexprheumatol\/s4c5k3","article-title":"Polymyalgia rheumatica without elevated baseline acute phase reactants","volume":"39","author":"Manzo C","year":"2021","unstructured":"Manzo C, Milchert M, Natale M, Brzosko M. Polymyalgia rheumatica without elevated baseline acute phase reactants. Clin Exp Rheumatol 2021; 39: 441.","journal-title":"Clin Exp Rheumatol"},{"key":"ref-786006","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2018.1048"},{"key":"ref-786007","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102670"},{"key":"ref-786008","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102995"},{"key":"ref-786009","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4598(200005)23:5<824::aid-mus24>3.0.co;2-m"},{"key":"ref-786010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52379_11.x"},{"key":"ref-786011","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435"},{"key":"ref-786012","doi-asserted-by":"publisher","DOI":"10.1002\/agm2.12171"},{"key":"ref-786013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105282"},{"key":"ref-786014","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8651-21"},{"key":"ref-786015","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105334"},{"key":"ref-786016","first-page":"088","article-title":"Are subdeltoid bursitis and polymyalgia rheumatica preferences of COVID-19 vaccine?","volume":"16","author":"Rozin AP","year":"2021","unstructured":"Rozin AP. Are subdeltoid bursitis and polymyalgia rheumatica preferences of COVID-19 vaccine? Int J Clin Rheumatol 2021; 16: 088\u2013 089.","journal-title":"Int J Clin Rheumatol"},{"key":"ref-786017","doi-asserted-by":"publisher","DOI":"10.3390\/rheumato1010004"},{"key":"ref-786018","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab756"},{"key":"ref-786019","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221587"},{"key":"ref-786020","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8829-21"},{"key":"ref-786021","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311430222"},{"key":"ref-786022","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102732"},{"key":"ref-786023","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2019.19152"},{"key":"ref-786024","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2020.95360"},{"key":"ref-786025","volume-title":"User manual for the revised WHO classification","author":"World Health","year":"2018","unstructured":"World Health Organization. User manual for the revised WHO classification, second edition. WHO, Geneve 2018.","edition":"second edition"},{"key":"ref-786026","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101436"},{"key":"ref-786027","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.12.001"},{"key":"ref-786028","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.03.007"},{"key":"ref-786029","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13874"},{"key":"ref-786030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2035343"},{"key":"ref-786031","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab849"},{"key":"ref-786032","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.012."},{"key":"ref-786033","first-page":"795","article-title":"Toll-like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"29","author":"Alvarez-Rodriguez L","year":"2011","unstructured":"Alvarez-Rodriguez L, Lopez-Hoyos M, Beares I, . Toll-like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Clin Exp Rheumatol 2011; 29: 795\u2013 800.","journal-title":"Clin Exp Rheumatol"},{"key":"ref-786034","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03791-x"},{"key":"ref-786035","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.79"}],"container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/reu.termedia.pl\/pdf-147677-86051","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reu.termedia.pl\/pdf-147677-86051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T07:57:14Z","timestamp":1674806234000},"score":1,"resource":{"primary":{"URL":"https:\/\/reu.termedia.pl\/Polymyalgia-rheumatica-and-polymyalgia-like-syndromes-as-adverse-events-following,147677,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"alternative-id":["147677"],"URL":"https:\/\/doi.org\/10.5114\/reum.2022.115665","relation":{},"ISSN":["0034-6233","2084-9834"],"issn-type":[{"value":"0034-6233","type":"print"},{"value":"2084-9834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,30]]}}}